Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
South Moon, Rebright, and FivFivGo eye drops are copycat products of Bausch + Lomb’s Lumify brand eye drops and should not be available in the US, according to a safety alert issued by the Food and Drug Administration (FDA).
Though it is unclear where these products originated, samples of the South Moon and Rebright eye drops were purchased online and tested by the Agency. While Rebright tested negative for contamination, South Moon was found to be contaminated with Burkholderia cepacia complex.
Additional testing found that the South Moon and Rebright eye drop products both lacked brimonidine tartrate, the active ingredient in Lumify. The Agency could not obtain samples of FivFivGo for testing.
To date, there have been no adverse event reports specifically linked to these products, though the FDA has received reports indicating quality concerns, eye irritation, pain and infection related to a possibly fake Lumify product.
The Agency is warning consumers not to purchase South Moon, Rebright, or FivFivGo eye drops due to the potential risk for eye infection. Adverse events related to these products should be reported to the FDA’s MedWatch reporting program.
References:
US Food and Drug Administration. FDA warns consumers of contaminated copycat eye drops. Accessed January 31, 2024. https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-consumers-contaminated-copycat-eye-drops.
